01 January 2001
Receptor-mediated activation of the heterotrimeric G-protein Gs results inATP release from erythrocytes.
Jeffrey J Olearczyk, Alan H Stephenson, Andrew J Lonigro, Randy S SpragueMed Sci Monit 2001; 7(4): BR669-674 :: ID: 421087
Abstract
BACKGROUND: Adenosine triphosphate (ATP), released from the erythrocytein response to mechanical deformation, decreased oxygen tension or reduced pH, has been suggested tobe an important determinant of vascular resistance in several vascular beds. Mechanical deformation-inducedATP release from rabbit and human erythrocytes was reported to require the activity of the cystic fibrosistransmembrane conductance regulator (CFTR), suggesting that a signal transduction pathway involving CFTRmediates ATP release from erythrocytes. Here we investigate the hypothesis that the heterotrimeric G-proteinGs is also involved in this signal transduction pathway.
Materials and methods: The heterotrimeric G-proteinGs was identified in rabbit and human erythrocyte membranes, using gel electrophoresis. The concentrationof ATP released into a suspension of erythrocytes, incubated with iloprost or epinephrine, was measuredusing the luciferin/luciferase assay.
RESULTS: The 45 kDa form of the heterotrimeric G-protein Gs wasidentified in rabbit and human erythrocyte membranes. Incubation of rabbit erythrocytes with iloprost(n=18) or epinephrine (n=6) increased the ATP concentration by 106+/-16% and 156+/-54%, respectively.Epinephrine-induced changes in ATP concentrations were prevented by pretreatment with propranolol.
CONCLUSIONS:The heterotrimeric G-protein Gs is present in erythrocyte membranes. Receptor-mediated activation ofGs results in ATP release. These results are consistent with the hypothesis that Gs is a component ofa signal transduction pathway for ATP release from erythrocytes.
Keywords: ATP, erythrocyte, heterotrimeric G-protein Gs
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
18 Mar 2024 : Clinical Research
Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative StudyMed Sci Monit In Press; DOI: 10.12659/MSM.944136
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
Most Viewed Current Articles
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952